BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colaci CS, Mendizabal M, Bessone F. Idiosyncratic Drug-Induced Acute Liver Failure: A Challenging and Distressing Scenario. Curr Drug Saf 2019;14:94-101. [PMID: 30767751 DOI: 10.2174/1574886314666190215115434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Teschke R, Danan G. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Medicines (Basel) 2020;7:E62. [PMID: 33003400 DOI: 10.3390/medicines7100062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
2 Bessone F, Hernandez N, Tagle M, Arrese M, Parana R, Méndez-Sánchez N, Ridruejo E, Mendizabal M, Dagher L, Contreras F, Fassio E, Pesoa M, Brahm J, Silva M. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver. Ann Hepatol 2021;24:100321. [PMID: 33609753 DOI: 10.1016/j.aohep.2021.100321] [Reference Citation Analysis]
3 Liu T, Tian M, Wang J, Tian X, Liu J, Feng L, Ma X, Cui J. Rational design of a fluorescent probe for the detection of LAP and its application in drug-induced liver injury. Spectrochim Acta A Mol Biomol Spectrosc 2021;251:119362. [PMID: 33486435 DOI: 10.1016/j.saa.2020.119362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
4 Hernandez N, Pontet Y, Bessone F. Translating new knowledge on drug-induced liver injury into clinical practice. Frontline Gastroenterol 2020;11:303-10. [PMID: 32587673 DOI: 10.1136/flgastro-2018-101120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]